With all the hype around AI, business partners and legal professionals are scrambling to understand, adapt, and possibly implement the ...

The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to ...

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

California is leading the way in ensuring that determinations of medically necessary health care services are made by licensed physicians and ...

Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

The victim count from last year's data breach has increased significantly. The number of victims impacted by the Change ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.

Wall Street opens up on relief Meta and Microsoft kept their AI spending plans even as their earnings come in mixed. Next up, Apple after the close.